The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Mycophenolate Mofetil 500 mg Film-coated Tablets



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/039/001

Main Information

Trade NameMycophenolate Mofetil 500 mg Film-coated Tablets
Active SubstancesMYCOPHENOLATE MOFETIL
Dosage FormFilm-coated tablet
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/039/001

Group Information

ATC CodeL04AA Selective immunosuppressants
L04AA06 mycophenolic acid

Status

License statusAuthorised
Licence Issued20/11/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back